Literature DB >> 20060497

Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas.

Andreas Lemke1, Albrecht F Kiderlen, Boris Petri, Oliver Kayser.   

Abstract

Amphotericin B was formulated as nanosuspensions to develop a nanoparticulate brain delivery system. Nanosuspensions were produced with different surfactant solutions by high-pressure homogenization and then characterized by laser diffractometry and photon correlation spectroscopy. Before in vitro and in vivo testing all nanosuspensions were investigated for protein adsorption by two-dimensional polyacrylamide gel electrophoresis to predict brain-targeting capacities. Selected nanosuspensions were tested for amebicidal activity against Balamuthia mandrillaris, an agent of lethal encephalitis. Our results indicate that nanosuspensions coated with polysorbate 80 and sodium cholate markedly increased drug brain delivery and inhibited the parasite in vitro, though less in vivo. From the clinical editor: The antifungal Amphotericin B was formulated as nanosuspensions to develop a nanoparticulate brain delivery system. The results indicate that nanosuspensions coated with polysorbate 80 and sodium cholate markedly increased drug brain delivery and inhibited the parasite in vitro, though less in vivo. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060497     DOI: 10.1016/j.nano.2009.12.004

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  12 in total

1.  Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound.

Authors:  Rohit S Mulik; Chenchen Bing; Michelle Ladouceur-Wodzak; Imalka Munaweera; Rajiv Chopra; Ian R Corbin
Journal:  Biomaterials       Date:  2016-01-06       Impact factor: 12.479

2.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

3.  Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres.

Authors:  A Gharib; Z Faezizadeh; H Mohammad Asghari
Journal:  Daru       Date:  2011       Impact factor: 3.117

Review 4.  Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier.

Authors:  Julia V Georgieva; Dick Hoekstra; Inge S Zuhorn
Journal:  Pharmaceutics       Date:  2014-11-17       Impact factor: 6.321

5.  Management of granulomatous amebic encephalitis: Laboratory diagnosis and treatment.

Authors:  Subhash Chandra Parija; Kp Dinoop; Hrudya Venugopal
Journal:  Trop Parasitol       Date:  2015 Jan-Jun

Review 6.  Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.

Authors:  Maria Rosa Gigliobianco; Cristina Casadidio; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2018-08-21       Impact factor: 6.321

7.  Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss.

Authors:  So-Young Jung; Subin Kim; Zion Kang; Soonmin Kwon; Juhye Lee; Joo Won Park; Kab Sig Kim; Dong-Kee Kim
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

8.  Isoniazid Conjugated Magnetic Nanoparticles Loaded with Amphotericin B as a Potent Antiamoebic Agent against Acanthamoeba castellanii.

Authors:  Kawish Iqbal; Sumayah Abdelnasir Osman Abdalla; Ayaz Anwar; Kanwal Muhammad Iqbal; Muhammad Raza Shah; Areeba Anwar; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Antibiotics (Basel)       Date:  2020-05-25

Review 9.  Emerging role of nanosuspensions in drug delivery systems.

Authors:  Shery Jacob; Anroop B Nair; Jigar Shah
Journal:  Biomater Res       Date:  2020-01-15

Review 10.  Nanoparticles for antiparasitic drug delivery.

Authors:  Yuzhu Sun; Dongmei Chen; Yuanhu Pan; Wei Qu; Haihong Hao; Xu Wang; Zhenli Liu; Shuyu Xie
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.